HB640

2022 Regular Session

Other Sessions

House Committees

Senate Committees

Miscellaneous Committees

Scheduled Meetings

Representatives

Senators

Caucuses and Delegations

2022 Regular Session

HB640 by Representative Mark Wright

VACCINES/VACCINATION: Provides relative to vaccines and vaccine-related pharmaceuticals produced with aborted human fetal-derived cells or human embryonic-derived cells (EGF NO IMPACT See Note)

Current Status: Subject to call - House final passage

House Floor Amendment #4361 Wright Proposed

House Floor Amendment #3849 Wright Adopted

House Committee Amendment #2582 H&W Adopted

House Committee Amendment #2535 H&W Draft

Digest of HB640 Engrossed

Digest of HB640 Original

Fiscal Note - HB640 Engrossed With House Floor Amendments

House Vote on HB 640 AMENDMENT # 3849 BY WRIGHT MOTION TO ADOPT (#712)

Mark Wright (primary)

Date	Chamber	Journal Page	Action
05/09	H	32	Read by title, amended, returned to the calendar.
05/09	H	32	Called from the calendar.
05/05	H		Scheduled for floor debate on 05/09/2022.
05/05	H	29	Notice given.
05/02	H	34	Read by title, returned to the calendar.
05/02	H	34	Called from the calendar.
04/27	H		Scheduled for floor debate on 05/02/2022.
04/27	H	33	Notice given.
04/27	H	33	Read by title, returned to the calendar.
04/27	H	33	Called from the calendar.
04/26	H		Scheduled for floor debate on 04/27/2022.
04/26	H	17	Notice given.
04/26	H	17	Read by title, returned to the calendar.
04/20	H		Scheduled for floor debate on 04/26/2022.
04/18	H	21	Read by title, amended, ordered engrossed, passed to 3rd reading.
04/13	H	23	Reported with amendments (7-5).
03/14	H	75	Read by title, under the rules, referred to the Committee on Health and Welfare.
03/04	H		First appeared in the Interim Calendar on 3/4/2022.
03/04	H		Under the rules, provisionally referred to the Committee on Health and Welfare.
03/04	H		Prefiled.